肝类器官中TP53 R249S突变捕捉易感癌症风险
该研究利用人肝类器官模拟肝细胞癌起始阶段,通过CRISPR敲除TP53并过表达R249S突变体,发现TP53缺失导致类器官肿瘤样形态改变和干性增加,R249S过表达进一步增强致瘤潜能和异种移植中真实的肝细胞癌组织学。ChIP-seq分析揭示L3环p53突变体在染色质重塑和克服外源应激方面具有功能获得性,R249S直接转录激活PSMF1增加内质网应激抵抗,PSMF1敲低可逆转此效应。患者队列和基因编辑类器官的定量PCR验证了ChIP-seq发现。
要点
- TP53敲除肝类器官呈现肿瘤样形态改变、干性增加和体外无限增殖。
- 在TP53敲除类器官中过表达R249S突变体,致瘤潜能自发增加并在异种移植中观察到真实肝细胞癌组织学。
- R249S通过直接转录激活PSMF1增强类器官对内质网应激的抵抗,PSMF1敲低可消除此抵抗。
核心结论
- TP53缺失和L3突变具有不同的致瘤效应,二者共同赋予正常肝细胞早期克隆优势和促生存功能。
研究设计与样本
- 研究利用手术非肿瘤肝组织生成人肝类器官,通过CRISPR敲除TP53并在TP53敲除类器官中过表达R249S突变体,结合HCC细胞系ChIP-seq分析、异种移植实验及患者原发HCC肿瘤队列和基因编辑肝类器官的定量PCR验证。
主要发现
- 肝类器官中CRISPR敲除TP53一致显示肿瘤样形态改变、干性增加和体外无限增殖。
- 在TP53敲除类器官中过表达R249S,观察到致瘤潜能自发增加和异种移植中真实的HCC组织学。
- HCC细胞系ChIP-seq分析强调L3环p53突变体在染色质重塑和克服外源应激方面具有功能获得性。
- 突变R249S直接转录激活PSMF1可增加类器官对内质网应激的抵抗,PSMF1敲低在拯救实验中可消除此抵抗。
- 在原发HCC肿瘤患者队列和基因编辑肝类器官中,定量PCR证实ChIP-seq发现并验证L3突变体优先调节的基因,尤其是R249S富集的基因。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Major genomic drivers of hepatocellular carcinoma (HCC) are nowadays well recognized, although models to establish their roles in human HCC initiation remain scarce. Here, we used human liver organoids in experimental systems to mimic the early stages of human liver carcinogenesis from the genetic lesions of TP53 loss and L3 loop R249S mutation. In addition, chromatin immunoprecipitation sequencing (ChIP-seq) of HCC cell lines shed important functional insights into the initiation of HCC consequential to the loss of tumor-suppressive function from TP53 deficiency and gain-of-function activities from mutant p53. APPROACH AND RESULTS: Human liver organoids were generated from surgical nontumor liver tissues. CRISPR knockout of TP53 in liver organoids consistently demonstrated tumor-like morphological changes, increased in stemness and unrestricted in vitro propagation. To recapitulate TP53 status in human HCC, we overexpressed mutant R249S in TP53 knockout organoids. A spontaneous increase in tumorigenic potentials and bona fide HCC histology in xenotransplantations were observed. ChIP-seq analysis of HCC cell lines underscored gain-of-function properties from L3 loop p53 mutants in chromatin remodeling and overcoming extrinsic stress. More importantly, direct transcriptional activation of PSMF1 by mutant R249S could increase organoid resistance to endoplasmic reticulum stress, which was readily abrogated by PSMF1 knockdown in rescue experiments. In a patient cohort of primary HCC tumors and genome-edited liver organoids, quantitative polymerase chain reaction corroborated ChIP-seq findings and verified preferential genes modulated by L3 mutants, especially those enriched by R249S. CONCLUSIONS: We showed differential tumorigenic effects from TP53 loss and L3 mutations, which together confer normal hepatocytes with early clonal advantages and prosurvival functions.
引用
- Lam YK, Yu J, Huang H, et al. TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk. Hepatology. 2022. PMID: 36221953. doi:10.1002/hep.32802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。